AMCO HAS MONOPOLY ON 50+ GENERICS
After doing some research on the drugs they own..i think these drugs are going to keep on churning cash . They are going to add 40 more products in 2017. They already have launched 20 so far this year. This will all add to revenue..i see no problems buying these shares here at these levels for a decent return.